L. Madero et al., Use of concurrent G-CSF plus GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease, BONE MAR TR, 26(4), 2000, pp. 365-369
Citations number
30
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
There is limited experience in the mobilization of peripheral blood progeni
tor cells (PBPC) in children and the optimal method for PBPC mobilization i
s unknown. The present study was conducted to ascertain whether mobilizatio
n with G-CSF + GM-CSF (group I) provides some advantage over G-CSF alone (g
roup II) in terms of collected CD34(+) cells and hematopoietic recovery fol
lowing myeloablative conditioning in children with malignancies. An economi
c analysis was also performed. Each group comprised 21 consecutive patients
. The mean number of aphereses was 1.5 +/- 0.5 in group I and 1.2 +/- 0.46
in group II (NS), The mean number of CD34(+) cells was 3.8 x 10(6) +/- 4.03
/kg in group I and 4.2 +/- 5.4 in group II (IVS). The mean number of total
blood volumes (TBV) processed was 4.4 +/- 1.5 in group I and 4.3 +/- 1.5 in
group II (NS). The mean duration of the procedure was 276 +/- 74.1 min in
group I and 286.7 +/- 75.9 min in group II (NS), and the inlet flow was 45.
1 +/- 12 ml/min in group I and 39.5 +/- 15.1 ml/min in group II (NS), No si
gnificant differences in the neutrophil and platelet engraftment probabilit
y were observed between the two groups. The mean overall cost of group II w
as not statistically significant from that of group I (US$ 9521 +/- 330 vs
US$ 10201 +/- 1028, P = NS). The cost of mobilization was significantly hig
her in group I than in group Ill conditioning regimen costs were similar in
both groups and the costs related to the post-transplant period were simil
ar in both groups. We conclude that PBPC mobilization with G-CSF + GM-CSF i
n children does not enhance hematological recovery in comparison with mobil
ization using S-CSF alone. However, the combination of G-CSF + GM-CSF does
not significantly increase the overall cost of transplantation.